A 2-fold ULN increased risk of elevation levels of ALT has been reported in individuals exhibiting the GSTM1 (−) allele among patients treated with isoniazid, rifampicin and pyrazinamide for pulmonary tuberculosis [26, 27]. The gene discussed is GSTM1; the disease is pulmonary tuberculosis.